Synopsis

Regulatory Lessons From the Meme Economy

Regulatory Lessons From the Meme Economy

Scholars review the rise and fall of GameStop stock and urge updates to securities laws.

Protecting the Right to Express Milk

Protecting the Right to Express Milk

Scholar argues that lactation policies need to do more to protect parents’ rights.

The Social Responsibility of Social Media Platforms

The Social Responsibility of Social Media Platforms

Scholar weighs options for putting an end to harmful speech on social media platforms.

Robots Reviewing Agency Rules

Robots Reviewing Agency Rules

Scholar warns that using artificial intelligence to revise agency rules may compromise democratic ideals.

Shifting Mandated Reporting Laws From Family Surveillance to Assistance

Shifting Mandated Reporting Laws From Family Surveillance to Assistance

Scholars advocate revising mandated reporting requirements for school employees.

Could Biometric Tracking Harm Workers?

Could Biometric Tracking Harm Workers?

Expert urges regulators to restrict how companies can access and use employee health data.

The Forgotten Cities

The Forgotten Cities

Scholars criticize regulatory decisions that funneled economic growth away from inland cities.

U.S. Foreign Anti-Corruption Regulation Spurs Economic Growth

U.S. Foreign Anti-Corruption Regulation Spurs Economic Growth

Scholars posit that FCPA regulation may improve economic conditions in developing countries.

Paying the Price of Regulating Childcare

Paying the Price of Regulating Childcare

Scholars argue that increased regulation in the childcare industry has unintended consequences.

Rejecting Two-Faced Explanations by Agencies

Rejecting Two-Faced Explanations by Agencies

Scholar argues that recent Supreme Court decisions create a new vision of agency accountability to the public.

The Space Debris Race

The Space Debris Race

Scholar evaluates options to strengthen international space debris regulations.

Value-Pricing Prescription Drugs

Value-Pricing Prescription Drugs

Scholar argues that reducing pricing for prescription drugs may increase innovation.